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Background
Enterococcus faecium and Pseudomonas aeruginosa are
part of the ESCAPE pathogens, which have the ability to
“escape” the currently available therapeutic options. For
these germs alternatives are needed, as is the case of
bacteriophage treatment.
Methods
In this study we used a bacteriophage testing kit contain-
ing 4 types of Georgian products: PYO, INTESTI (Eliava
BioPreparations, Tbilisi) and PHAGYO, PHAGESTI (JSC
“Biochimpharm”, Tbilisi) to test the strains of Pseudomo-
nas spp. and Enterococcus spp. isolated and stored from
patients treated in the Adults II ward of the National
Institute for Infectious Diseases “Prof. Dr. Matei Balş”,
Romania during April 2013 – July 2014.
Results
We identified 9 strains of Enterococcus (7 E. faecalis, 1
E. avium and 1 E. faecium) and 9 strains of Pseudomonas
aeruginosa. The strains had been isolated mostly from
cutaneous wounds (3/9) for Enterococcus spp. and from
urine (5/9) for P. aeruginosa. For Enterococcus spp. the
rate of susceptibility to PYO phages was 33.33% (3/9), to
INTESTI 55.56% (5/9), to PHAGYO 44.44% (4/9) and to
PHAGESTI 0% (0/9). We tested the Enterococcus ATTC,
and it displayed susceptibility to PYO, INTESTI and
PHAGYO.
For Pseudomonas spp. the rate of susceptibility to
PYO phages was of 66.67% (6/9), INTESTI 88.89% (8/9),
PHAGYO 55.56% (5/9), PHAGESTI 44.44% (4/9).
We tested the Pseudomonas ATTC, and it displayed
susceptibility to all the bacteriophage products tested.
Performing the ANOVA test for Enterococcus spp. we
identified a statistically significant correlation between
susceptibility to ampicillin vs. PYO phages (p = 0.034)
and vs. INTESTI phages (p = 0.024). For P. aeruginosa a
correlation was identified between susceptibility to cefta-
zidime and PYO phages (p = 0.029).
Conclusion
Despite the fact that PYO and PHAGYO do not contain
phages for Enterococcus spp., their activity against it was
similar to that of INTESTI. PYO and PHAGYO showed
activity on Enterococcus ATCC, too. For P. aeruginosa
the rate of susceptibility was very high for phages, and
quite low for almost all antibiotics tested. We intend to
develop further studies for testing a higher number
of strains and for assessing a potential synergy for
co-administration of antibiotics and bacteriophages.
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